ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 401

Racial and Ethnic Disparities in Depression Diagnosis and Treatment for Adolescents with SLE: Analysis of a National Medicaid Sample

Andrea Knight1, Ming Xie2 and David Mandell3, 1Pediatrics/Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Center for Mental Health Policy and Services Research, Philadelphia, PA, 3Psychiatry and Pediatrics, University of Pennsylvania, Center for Mental Health Policy and Services Research, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adolescent patients, depression and pediatric rheumatology, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster I: Lupus, Scleroderma, JDMS

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:
Adolescents with systemic lupus erythematosus (SLE) are at
high risk for depression. Racial/ethnic minorities are
disproportionately affected by SLE, and previous studies suggest a
higher risk of untreated depression in these groups. We aimed to compare the
prevalence of diagnosed depression and treatment between racial/ethnic groups
of adolescents with SLE.

Methods:
We conducted a cross-sectional study using claims data from
the Centers for Medicare and Medicaid Services Medicaid Analytic Extract data
files from 49 states and the District of Columbia. We included adolescents aged
10 to 18 years, with continuous enrollment from January 1, 2006 to December 31,
2007, and a diagnosis of SLE, defined as having >=3 outpatient visit claims
with an ICD-9 primary diagnosis code for SLE of 710.0, each recorded at least
30 days apart. We categorized race/ethnicity as: white, African-American,
Latino and other. We conducted unadjusted and adjusted logistic regression
analyses to compare the following between racial/ethnic groups: 1) depression
diagnoses and 2) antidepressant use. Covariates included: age, sex, urban vs.
rural location, presence of SLE nephritis and central nervous system (CNS)
disease, defined as seizures or stroke.

Results:
We identified 970
adolescents with SLE; 15% were white, 42% African American, 27% Latino and 16%
of other races/ethnicities. The mean age was 14.7 (SD=2.0), 83% were female and
85% were of urban location. Nephritis was present in 36% and CNS disease in
16%. Seventeen percent of the sample had depression diagnosis and 21% used an antidepressant.
In adjusted analyses, African-Americans were less likely than whites to have a depression
diagnosis (OR=0.5, 95%CI 0.3-0.8, p<0.01) or use an antidepressant (OR=0.5,
95%CI 0.3-0.8, p<0.05) (Figure 1). Older adolescents were more likely to be
diagnosed with depression (OR=1.1, 95% CI 1.0-1.2, p<0.01) and use an antidepressant
(OR=1.2, 95% CI 1.1-1.3, p<0.001), as were those with CNS disease (OR=2.9,
95% CI 2.0-4.3, p<0.001).

Conclusion:
In the context of other studies showing under-treatment of
depression in African-American adolescents, our results suggest that
African-Americans with SLE may be at higher risk for under-diagnosis and
under-treatment than adolescents with SLE of other race/ethnicity.
Interventional strategies for depression in adolescents with SLE should address
disparities in mental health care.

 


Disclosure: A. Knight, None; M. Xie, None; D. Mandell, None.

To cite this abstract in AMA style:

Knight A, Xie M, Mandell D. Racial and Ethnic Disparities in Depression Diagnosis and Treatment for Adolescents with SLE: Analysis of a National Medicaid Sample [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/racial-and-ethnic-disparities-in-depression-diagnosis-and-treatment-for-adolescents-with-sle-analysis-of-a-national-medicaid-sample/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-and-ethnic-disparities-in-depression-diagnosis-and-treatment-for-adolescents-with-sle-analysis-of-a-national-medicaid-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology